AKT1 and intrahepatic cholangiocarcinoma: Recent studies have demonstrated that PlGF blockade reduces desmoplasia via Akt-NF-kB signaling, enhancing chemotherapy efficacy in intrahepatic cholangiocarcinoma (ICC)25.